Terns Pharmaceuticals Inc (TERN)
5.44
+0.15
(+2.84%)
USD |
NASDAQ |
May 03, 16:00
5.435
0.00 (0.00%)
After-Hours: 20:00
Terns Pharmaceuticals Accounts Payable (Quarterly): 2.515M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.515M |
| September 30, 2023 | 3.325M |
| June 30, 2023 | 5.537M |
| March 31, 2023 | 2.69M |
| December 31, 2022 | 1.645M |
| September 30, 2022 | 2.094M |
| June 30, 2022 | 0.973M |
| March 31, 2022 | 1.678M |
| Date | Value |
|---|---|
| December 31, 2021 | 2.126M |
| September 30, 2021 | 1.582M |
| June 30, 2021 | 1.688M |
| March 31, 2021 | 4.25M |
| December 31, 2020 | 0.935M |
| September 30, 2020 | 0.461M |
| December 31, 2019 | 1.636M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.461M
Minimum
Sep 2020
5.537M
Maximum
Jun 2023
2.209M
Average
1.688M
Median
Jun 2021
Accounts Payable (Quarterly) Benchmarks
| Viking Therapeutics Inc | 5.225M |
| Eli Lilly and Co | 2.474B |
| Pfizer Inc | 6.71B |
| Amgen Inc | 1.628B |
| Madrigal Pharmaceuticals Inc | 28.04M |